Astrana Health, Inc.
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
ASTH$32.18-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 8. Financial Statements and Supplementary Data
| Index to the Consolidated Financial Statements | Page |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 42) | 90 |
| Consolidated Balance Sheets as of December 31, 2025 and 2024 | 93 |
| Consolidated Statements of Income for the Years Ended December 31, 2025, 2024, and 2023 | 94 |
| Consolidated Statements of Mezzanine and Stockholders’ Equity (Deficit) for the Years Ended December 31, 2025, 2024, and 2023 | 95 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2025, 2024, and 2023 | 96 |
| Notes to the Consolidated Financial Statements | 97 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.